Apollo Hospitals Will Invest ₹6,000 Cr To Add 3,500 Beds

Rise in cancer, diabetes cases prompts Apollo to expand hospital network across urban India

- Priyanka Sharma

In view of the growing incidence of non-communicable diseases (NCDs) such as cancer and diabetes, Apollo Hospitals Enterprise Ltd will invest ₹6,000 crore over five years to add 3,500 beds across key urban centres with a focus on high-burden specialties such as oncology, cardiology, neurosciences, and gastroenterology.

Speaking to Mint, Sangita Reddy, joint managing director, Apollo Hospitals, said the group is actively working to expand its presence through a strategic two-phase growth plan to bridge the country's critical hospital infrastructure gap. "Apollo is focused on strengthening its centres of excellence in cardiac sciences, oncology, neurosciences, orthopedics and gastro sciences," she said. "The expansion will add 3,512 beds through a combination of asset acquisitions, greenfield projects and brownfield developments."